FDA finalizes umbrella trial guidance for cell and gene therapies
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesBiotechnologyChemistry, Manufacturing and Controls (CMC)Clinical TrialsComplianceNorth AmericaRegulatory Intelligence/PolicyResearch, Design and Development